Social Responsibility

First Health Pharmaceuticals took its Social Responsibility very seriously when it donated the largest part of its antivirus pipeline to First Health United. The decision is testimony to the fact that profit maximization is clearly not the only goal of the company and that Social Responsibility is a driving force within the First Health group.

The antiviral research is a core of our operations:
The antiviral research is a core of our operations. The Dengue antivirus compound that First Health United wants to develop will target the Severe Dengue patient population of the developing countries (where Dengue is endemic).
Given the scientific research potential of First Health Pharmaceuticals based on the DDX3 helicase inhibiting antiviral agents and its prestigious academic partners, First Health United wants to make a real difference in the world by developing an effective Severe Dengue antivirus agent based on FHP’s patented IP, with the intention to make this antivirus available at cost price – or whenever possible for free – to developing countries worldwide.

We are different

Most non-profit organisations work at a national level, gravitating towards basic research in their country of origin. First Health United is different: We collaborate with whatever university is a leader in our field of research, regardless if it is in the Netherlands, China, Italy or the USA.

Here is a list of our current academic cooperation partners:

NorovirusCNR - Italian National Research Centre, IT
HIV University of Glasgow, UK
HCV Istituto Toscano Tumori, IT
Cancer targets, John Hopkins University Hospital, USA
Breast Cancer Nanjing Agricultural University, PRC
Japanese Encephalitis Virus Institut Pasteur, Lyon, FR
Ebola virus Rega Institue, KU Leuven, BE
Flaviviruses University of Rome La Cattolica del Sacro Cuore, IT
Toxicity and metabolism UC San Diego, USA
HIV, HCV Academic Hospital of Siena, IT
HIV, Arbo viruses US Army Medical Research Institute of Infectious Diseases, USA Ebola viru
University of Cambridge, Virology division, UK